and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and ...
That includes the Allurion Virtual Care Suite, our connected scale that actually measures and tracks muscle mass and the Allurion app, which is providing behavior change and lifestyle modification ...
Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the year ended ...
SplxAI, the leader in offensive security for Agentic AI, today announced it has closed $7M in seed funding led by LAUNCHub Ventures with participation from Rain Capital, Inovo, Runtime Ventures, DNV ...
and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for ...
Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session.
Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session. ...
Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $7 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $15.75 per share a year ago.
Allurion Technologies has a twelve month low of $2.15 and a twelve month high of $98.75. The firm’s 50-day moving average price is $4.00 and its 200 day moving average price is $10.10.
Allurion Technologies Inc. (ALUR) reported its Q4 2024 earnings, revealing a notable decline in revenue and gross profit compared to the previous year. Despite these challenges, the company outlined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results